Oncomyx Therapeutics

Provider of oncolytic virus-based immunotherapeutics

placePhoenix, Arizona, United States calendar_todayFounded 2018 groups17 employees language oncomyx.com

Registered entities

Investor mix

11 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Xeraya Capital, Delos Capital Partners, Lumira Ventures.

Investor typeCountShare
Venture capital764%
Private equity218%
Bank & private debt19%
Other / undisclosed19%
Coming soon